The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Regulation of MHC class II gene expression by the class II transactivator
Open accessAbstract
MHC class II molecules are pivotal for the adaptive immune system, because they guide the development and activation of CD4+ T helper cells. Fulfilling these functions requires that the genes encoding MHC class II molecules are transcribed according to a strict cell-type-specific and quantitatively modulated pattern. This complex gene-expression profile is controlled almost exclusively by a single master regulatory factor, which is known as the class II transactivator. As we discuss here, differential activation of the three independent promoters that drive expression of the gene encoding the class II transactivator ultimately determines the exquisitely regulated pattern of MHC class II gene expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Positive and negative selection of T cells
Starr, T. K., Jameson, S. C., & Hogquist, K. A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141107 · Cited by 1,601
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
Inohara, N., Chamaillard, M., McDonald, C., & Nuñez, G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133347 · Cited by 991
Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B. (1994) · Science · doi:10.1126/science.8016643 · Cited by 898
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
The molecular biology of the CCAAT-binding factor NF-Y
Mantovani, R. (1999) · Gene · doi:10.1016/s0378-1119(99)00368-6 · Cited by 861
McCarey, D. W., McInnes, I. B., Madhok, R., Hampson, R., Scherbakova, O., Ford, I., Capell, H. A., & Sattar, N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16449-0 · Cited by 818
Genetic Control of MHC Class II Expression
Ting, J. P.-Y., & Trowsdale, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00696-7 · Cited by 584
The Bare Lymphocyte Syndrome and the Regulation of MHC Expression
Reith, W., & Mach, B. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.331 · Cited by 518
Self-citationMuhlethaler-Mottet, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2851 · Cited by 507
Lymphostromal interactions in thymic development and function
Anderson, G., & Jenkinson, E. J. (2001) · Nature Reviews Immunology · doi:10.1038/35095500 · Cited by 460
A novel anti-inflammatory role for simvastatin in inflammatory arthritis.
Leung, B. P., Sattar, N., Crilly, A., Prach, M., McCarey, D. W., Payne, H., Madhok, R., Campbell, C., Gracie, J. A., Liew, F. Y., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1524 · Cited by 434
Muhlethaler-Mottet, A., Di Berardino, W., Otten, L. A., & Mach, B. (1998) · Immunity · doi:10.1016/s1074-7613(00)80468-9 · Cited by 377
Masternak, K., Muhlethaler-Mottet, A., Villard, J., Zufferey, M., Steimle, V., & Reith, W. (2000) · Genes & Development · doi:10.1101/gad.14.9.1156 · Cited by 355
Self-citationAnderson, G., Jenkinson, E. J., Moore, N. C., & Owen, J. J. T. (1993) · Nature · doi:10.1038/362070a0 · Cited by 351
Chang, C.-H., Guerder, S., Hong, S.-C., van Ewijk, W., & Flavell, R. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80681-0 · Cited by 350
CATERPILLER: A Novel Gene Family Important in Immunity, Cell Death, and Diseases
Ting, J. P.-Y., & Davis, B. K. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115616 · Cited by 347
Rimsza, L. M. (2004) · Blood · doi:10.1182/blood-2003-07-2365 · Cited by 344
Swanberg, M., Lidman, O., Padyukov, L., Eriksson, P., Åkesson, E., Jagodic, M., Lobell, A., Khademi, M., Börjesson, O., Lindgren, C. M., et al. (2005) · Nature Genetics · doi:10.1038/ng1544 · Cited by 339
Steimle, V, Durand, B., Barras, E., Zufferey, M., Hadam, M. R., Mach, B., & Reith, W. (1995) · Genes & Development · doi:10.1101/gad.9.9.1021 · Cited by 338
Self-citationMiller, D. M., Rahill, B. M., Boss, J. M., Lairmore, M. D., Durbin, J. E., Waldman, J. W., & Sedmak, D. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.675 · Cited by 337
Mini‐review: Specificity and expression of CIITA, the master regulator of MHC class II genes
LeibundGut‐Landmann, S., Waldburger, J., Krawczyk, M., Otten, L. A., Suter, T., Fontana, A., Acha‐Orbea, H., & Reith, W. (2004) · European Journal of Immunology · doi:10.1002/eji.200424964 · Cited by 277
Self-citationMasternak, K., Barras, E., Zufferey, M., Conrad, B., Corthals, G., Aebersold, R., Sanchez, J.-C., Hochstrasser, D. F., Mach, B., & Reith, W. (1998) · Nature Genetics · doi:10.1038/3081 · Cited by 276
Self-citationKanazawa, S., Okamoto, T., & Peterlin, B. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)80159-4 · Cited by 262
Reith, W., Satola, S., Sanchez, C. H., Amaldi, I., Lisowska-Grospierre, B., Griscelli, C., Hadam, M. R., & Mach, B. (1988) · Cell · doi:10.1016/s0092-8674(88)90389-3 · Cited by 255
Self-citationPai, R. K., Convery, M., Hamilton, T. A., Boom, W. H., & Harding, C. V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.175 · Cited by 246
RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency
Durand, B. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.1045 · Cited by 227
Piskurich, J. F., Lin, K. I., Lin, Y., Wang, Y., Ting, J. P. Y., & Calame, K. (2000) · Nature Immunology · doi:10.1038/82788 · Cited by 215
Gobin, S. J. P., Peijnenburg, A., Keijsers, V., & van den Elsen, P. J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80348-9 · Cited by 210
Induction of MHC Class I Expression by the MHC Class II Transactivator CIITA
Martin, B. K., Chin, K.-C., Olsen, J. C., Skinner, C. A., Dey, A., Ozato, K., & Ting, J. P.-Y. (1997) · Immunity · doi:10.1016/s1074-7613(00)80347-7 · Cited by 208
Zhong, G., Fan, T., & Liu, L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1931 · Cited by 196
Piskurich, J. F., Linhoff, M. W., Wang, Y., & Ting, J. P.-Y. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.431 · Cited by 187
CREB Regulates MHC Class II Expression in a CIITA-Dependent Manner
Moreno, C. S., Beresford, G. W., Louis-Plence, P., Morris, A. C., & Boss, J. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80015-1 · Cited by 184
Lee, Y. J., Han, Y., Lu, H. T., Nguyen, V, Qin, H., Howe, P. H., Hocevar, B. A., Boss, J. M., Ransohoff, R. M., & Benveniste, E. N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2065 · Cited by 177
Nagarajan, U. M., Louis-Plence, P., DeSandro, A., Nilsen, R., Bushey, A., & Boss, J. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80016-3 · Cited by 166
Landmann, S., Mühlethaler-Mottet, A., Bernasconi, L., Suter, T., Waldburger, J.-M., Masternak, K., Arrighi, J.-F., Hauser, C., Fontana, A., & Reith, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.379 · Cited by 164
Self-citationTranscriptional regulation of the MHC class II antigen presentation pathway
Boss, J. M., & Jensen, P. E. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00015-8 · Cited by 162
MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells
LeibundGut‐Landmann, S., Waldburger, J., Sousa, C. R. E., Acha‐Orbea, H., & Reith, W. (2004) · Nature Immunology · doi:10.1038/ni1109 · Cited by 158
Self-citationSilacci, P., Mühlethaler‐Mottet, A., Steimle, V., Reith, W., & Mach, B. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.4.1329 · Cited by 158
Self-citationO'Keefe, G. M., Nguyen, V. T., & Benveniste, E. N. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199904)29:04<1275::aid-immu1275>3.0.co;2-t · Cited by 157
Chromatin remodeling and extragenic transcription at the MHC class II locus control region
Masternak, K., Peyraud, N., Krawczyk, M., Barras, E., & Reith, W. (2003) · Nature Immunology · doi:10.1038/ni883 · Cited by 157
Self-citationHolling, T. M., van der Stoep, N., Quinten, E., & van den Elsen, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.763 · Cited by 151
Nagy, Z. A., Hubner, B., Löhning, C., Rauchenberger, R., Reiffert, S. U., Thomassen-Wolf, E., Zahn, S., Leyer, S., Schier, E. M., Zahradnik, A., et al. (2002) · Nature Medicine · doi:10.1038/nm736 · Cited by 149
Thymic generation and regeneration
Gill, J. W., Malin, M., Sutherland, J. S., Gray, D. H. D., Holländer, G. A., & Boyd, R. L. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00077.x · Cited by 144
Modulation of Major Histocompatibility Class II Protein Expression by Varicella-Zoster Virus
Abendroth, A., Slobedman, B., Lee, E. Y., Mellins, E., Wallace, M. R., & Arvin, A. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1900-1907.2000 · Cited by 139
CIITA-regulated plexin-A1 affects T-cell–dendritic cell interactions
Wong, A. W., Brickey, W. J., Taxman, D. J., van Deventer, H. W., REED, W. A., Gao, J. X., Zheng, P., Liu, Y., Li, P., Blum, J. S., et al. (2003) · Nature Immunology · doi:10.1038/ni960 · Cited by 135
Waldburger, J., Suter, T. B., Fontana, A., Acha‐Orbea, H., & Reith, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.393 · Cited by 132
Self-citationMorris, A. C., Beresford, G., Mooney, M. R., & Boss, J. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4781-4791.2002 · Cited by 130
The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32
Fontes, J. D., Jiang, B., & Peterlin, B. M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2522 · Cited by 126
O'Keefe, G. M., Nguyen, V., Tang, L.-P., & Benveniste, E. (2001) · Journal of Immunology · doi:10.4049/jimmunol.166.4.2260 · Cited by 119
Interferon‐γ‐induced chromatin remodeling at the CIITA locus is BRG1 dependent
Pattenden, S. G., Klose, R. J., Karaskov, E., & Bremner, R. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1978 · Cited by 119
Toes, R. E. M., Schoenberger, S. P., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0147 · Cited by 117
Mahanta, S. K., Scholl, T., Yang, F.-C., & Strominger, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6324 · Cited by 111
Wojciechowski, W., Sanctis, J. B. D., Skamene, E., & Radzioch, D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2688 · Cited by 109
Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases.
Guardiola, J., & Maffei, A. (1993) · PubMed · Cited by 109
Raval, A., Howcroft, T. K., Weissman, J. D., Kirshner, S., Zhu, X.-S., Yokoyama, K. K., Ting, J. P. ‐., & Singer, D. S. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00159-9 · Cited by 108
Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator
Pai, R. K., Askew, D. S., Boom, W. H., & Harding, C. V. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1326 · Cited by 107
Enhancement of CIITA transcriptional function by ubiquitin
Greer, S. F., Zika, E., Conti, B. J., Zhu, X.-S., & Ting, J. P.-Y. (2003) · Nature Immunology · doi:10.1038/ni985 · Cited by 106
Sisk, T. J., Gourley, T. S., Roys, S., & Chang, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2511 · Cited by 106
Meazza, R., Comes, A., Orengo, A. M., Ferrini, S., & Accolla, R. S. (2003) · European Journal of Immunology · doi:10.1002/eji.200323712 · Cited by 104
Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes
Zika, E., & Ting, J. P.-Y. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.11.008 · Cited by 97
Methylation of Class II trans-Activator Promoter IV: A Novel Mechanism of MHC Class II Gene Control
Morris, A. C., Spangler, W. E., & Boss, J. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4143 · Cited by 95
Lüder, C. G. K., Lang, C., Giraldo‐Velásquez, M., Algner, M., Gerdes, J., & Groß, U. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00320-x · Cited by 94
CIITA regulates transcription onset via Ser5‐phosphorylation of RNA Pol II
Spilianakis, C. G., Kretsovali, A., Agalioti, T., Makatounakis, T., Thanos, D., & Papamatheakis, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg496 · Cited by 89
IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
Dong, Y., Rohn, W. M., & Benveniste, E. N. (1999) · PubMed · Cited by 89
Modulation of Gene Expression by the MHC Class II Transactivator
Nagarajan, U. M., Long, A. B., & Boss, J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5078 · Cited by 87
Assessment of the efficacy of different statins in murine collagen‐induced arthritis
Palmer, G., Chobaz, V., Talabot‐Ayer, D., Taylor, S., So, A. K.-L., Gabay, C., & Busso, N. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20673 · Cited by 83
Roy, E. L., Mühlethaler‐Mottet, A., Davrinche, C., Mach, B., & Davignon, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6582-6589.1999 · Cited by 82
Isolation of a B-cell-specific promoter for the human class II transactivator
Lennon, A., Ottone, C., Rigaud, G., Deaven, L. L., Longmire, J., Fellous, M., Bono, R., & Alcaïde‐Loridan, C. (1997) · Immunogenetics · doi:10.1007/s002510050202 · Cited by 81
Nickerson, K. M., Sisk, T. J., Inohara, N., Yee, C. S. K., Kennell, J. A., Cho, M.-C., Yannie, P. J., Núñez, G., & Chang, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101295200 · Cited by 79
Dong, Y., Tang, L., Letterio, J. J., & Benveniste, E. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.311 · Cited by 77
IFN-γ Regulation of the Type IV Class II Transactivator Promoter in Astrocytes
Dong, Y., Rohn, W. M., & Benveniste, E. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4731 · Cited by 75
Regulation of MHC class II expression in human T-cell malignancies
Holling, T. M., Schooten, E., Langerak, A. W., et al. (2003) · Blood · doi:10.1182/blood-2003-05-1491 · Cited by 74
In vitromodels of T cell development
Hare, K. J., Jenkinson, E. J., & Anderson, G. (1999) · Seminars in Immunology · doi:10.1006/smim.1998.0151 · Cited by 73
Deffrennes, V., Vedrenne, J., Stolzenberg, M., Piskurich, J. F., Barbieri, G., Ting, J. P. ‐., Charron, D. J., & Alcaïde‐Loridan, C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.98 · Cited by 72
Clausen, B. E., Waldburger, J., Schwenk, F., Barras, E., Mach, B., Rajewsky, K., Förster, I., & Reith, W. (1998) · Immunity · doi:10.1016/s1074-7613(00)80467-7 · Cited by 72
Self-citationvan den Elsen, P. J., van der Stoep, N., Viëtor, H. E., Wilson, L., van Zutphen, M., & Gobin, S. J. P. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00159-2 · Cited by 72
Zhu, X., & Ting, J. P. ‐. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.7078-7088.2001 · Cited by 69
Ghosh, N., Győry, I., Wright, G. M., Wood, J., & Wright, K. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100862200 · Cited by 68
Itoh-Lindstrom, Y., Piskurich, J. F., Felix, N. J., Wang, Y., Brickey, W. J., Platt, J. L., Koller, B. H., & Ting, J. P. ‐. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2425 · Cited by 67
van der Stoep, N., Biesta, P. J., Quinten, E., & van den Elsen, P. J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1623 · Cited by 66
Itoh-Lindstrom, Y., Piskurich, J. F., Felix, N. J., Wang, Y., Brickey, W. J., Platt, J. L., Koller, B. H., & Ting, J. P. ‐. (1999) · PubMed · Cited by 66
Tosi, G., Jabrane‐Ferrat, N., & Peterlin, B. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf557 · Cited by 65
Regulation of major histocompatibility complex class II gene expression in trophoblast cells
Murphy, S. P., Choi, J. C., & Holtz, R. (2004) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-2-52 · Cited by 63
Krawczyk, M., Peyraud, N., Rybtsova, N., Masternak, K., Bücher, P., Barras, E., & Reith, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6200 · Cited by 62
Self-citationInvariant chain alters the malignant phenotype of MHC class II+ tumor cells
Clements, V. K., Baskar, S., Armstrong, T. D., & Ostrand‐Rosenberg, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.7.2391 · Cited by 59
Tumour immunology, vaccination and escape strategies.
Garcia-Lora, A., Algarra, I., Collado, A., & Garrido, F. (2003) · European journal of immunogenetics · doi:10.1046/j.1365-2370.2003.00384.x · Cited by 59
van der Stoep, N., Quinten, E., Rezende, M. M., & van den Elsen, P. J. (2004) · Blood · doi:10.1182/blood-2004-03-0790 · Cited by 58
Nikcevich, K. M., Piskurich, J. F., Hellendall, R. P., Wang, Y., & Ting, J. P. ‐. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00117-4 · Cited by 54
Ghosh, N., Piskurich, J. F., Wright, G. M., Hassani, K., Ting, J. P. ‐., & Wright, K. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32342 · Cited by 54
Cathepsin E: A Novel Target for Regulation by Class II Transactivator
Yee, C. S. K., Yao, Y., Li, P., Klemsz, M. J., Blum, J. S., & Chang, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5528 · Cited by 53
Mudhasani, R., & Fontes, J. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5019-5026.2002 · Cited by 53
Morimoto, Y., Toyota, M., Satoh, A., Murai, M., Mita, H., Suzuki, H., Takamura, Y., Ikeda, H., Ishida, T., Sato, N., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601602 · Cited by 53
Regulation and Specificity of MHC2TA Promoter Usage in Human Primary T Lymphocytes and Cell Line
Wong, A. W., Ghosh, N., McKinnon, K. P., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3112 · Cited by 53
Xi, H., Eason, D. D., Ghosh, D., Dovhey, S. E., Wright, K. L., & Blanck, G. (1999) · Oncogene · doi:10.1038/sj.onc.1202969 · Cited by 49
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?
Altomonte, M., Fonsatti, E., Visintin, A., & Maio, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206960 · Cited by 48
van der Stoep, N., Quinten, E., & van den Elsen, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5061 · Cited by 47
Schnappauf, F., Hake, S. B., Camacho-Carvajal, M. M., Bontron, S., Lisowska‐Grospierre, B., & Steimle, V. (2003) · European Journal of Immunology · doi:10.1002/eji.200323490 · Cited by 47
Immune regulation in multiple myeloma: the host–tumour conflict
Cook, G., & Campbell, J. D. M. (1999) · Blood Reviews · doi:10.1054/blre.1999.0111 · Cited by 46
Sisk, T. J. (2003) · International Immunology · doi:10.1093/intimm/dxg116 · Cited by 44
Rohn, W. M., Tang, L. P., Dong, Y., & Benveniste, E. N. (1999) · PubMed · Cited by 43
HLA class II antibodies in the treatment of hematologic malignancies
Dechant, M., Bruenke, J., & Valerius, T. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00252-5 · Cited by 39
Dissanayake, S. K., Tuera, N. T., & Ostrand‐Rosenberg, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1811 · Cited by 39
Rohn, W. M., Tang, L. P., Dong, Y., & Benveniste, E. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.886 · Cited by 39
Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells
Waldburger, J., Rossi, S. W., Holländer, G. A., Rodewald, H.-R., Reith, W., & Acha‐Orbea, H. (2003) · Blood · doi:10.1182/blood-2002-06-1855 · Cited by 38
Self-citationGoodwin, B. L., Huang, X., Tejiram, R., Eason, D. D., Ghosh, N., Wright, K. L., Nagarajan, U. M., Boss, J. M., & Blanck, G. (2001) · PubMed · Cited by 38
Deregulated MHC Class II Transactivator Expression Leads to a Strong Th2 Bias in CD4+ T Lymphocytes
Otten, L., Tacchini‐Cottier, F., Lohoff, M. D., Annunziato, F., Cosmi, L., Scarpellino, L., Louis, J. A., Steimle, V., Reith, W., & Acha‐Orbea, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1150 · Cited by 36
Self-citationAberrant Expression of Fas Ligand in Mice Deficient for the MHC Class II Transactivator
Gourley, T. S., Patel, D. R., Nickerson, K. M., Hong, S., & Chang, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4414 · Cited by 36
Holtz, R., Choi, J. C., Petroff, M. G., Piskurich, J. F., & Murphy, S. P. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.103.017103 · Cited by 36
Greer, S. F., Harton, J. A., Linhoff, M. W., Janczak, C. A., Ting, J. P. ‐., & Cressman, D. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.376 · Cited by 35
Martin, B. K., Frelinger, J. G., & Ting, J. P. ‐. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6663 · Cited by 34
Mühlethaler‐Mottet, A., Krawczyk, M., Masternak, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406585200 · Cited by 34
Anderson, G., Hare, K. J., Platt, N., & Jenkinson, E. J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270803 · Cited by 33
Sartoris, S., Tosi, G., Barbaro, A. D. L., Cestari, T., & Accolla, R. S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261028 · Cited by 30
Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA)
Takamura, Y., Ikeda, H., Kanaseki, T., Toyota, M., Tokino, T., Imai, K., Houkin, K., & Sato, N. (2003) · Glia · doi:10.1002/glia.10343 · Cited by 29
Murphy, S. P., Holtz, R., Lewandowski, N. M., Tomasi, T. B., & Fuji, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3085 · Cited by 27
Casoli, C., Barbaro, A. D. L., Pilotti, E., Bertazzoni, U., Tosi, G., & Accolla, R. S. (2003) · Blood · doi:10.1182/blood-2003-07-2503 · Cited by 26
Liu, A., Takahashi, M., Toba, K., Zheng, Z., Hashimoto, S., Nikkuni, K., Furukawa, T., Koike, T., & Aizawa, Y. (1999) · Hematological Oncology · doi:10.1002/(sici)1099-1069(199912)17:4 · Cited by 22
Impaired class II transactivator expression in mice lacking interferon regulatory factor-2
Xi, H., Goodwin, B. L., Shepherd, A. T., & Blanck, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204556 · Cited by 21
Gao, J., De, B. P., Han, Y., Choudhary, S. K., Ransohoff, R. M., & Banerjee, A. K. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1124-1131.2001 · Cited by 20
Santos, A. N. (1998) · International Immunology · doi:10.1093/intimm/10.5.601 · Cited by 19
T cell expression of CIITA represses Th1 immunity
Park, W. S. (2004) · International Immunology · doi:10.1093/intimm/dxh132 · Cited by 19
Statins and control of MHC2TA gene transcription
Kuipers, H. F., & van den Elsen, P. J. (2005) · Nature Medicine · doi:10.1038/nm0405-365 · Cited by 18
Takeuchi, O., Sims, T. N., Takei, Y., Ramassar, V., Famulski, K. S., & Halloran, P. F. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000094084.18567.cc · Cited by 13
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Neefjes, J., Jongsma, M. L. M., Paul, P., & Bakke, O. (2011) · Nature Reviews Immunology · doi:10.1038/nri3084 · Cited by 2,044
The ins and outs of MHC class II-mediated antigen processing and presentation
Roche, P. A., & Furuta, K. (2015) · Nature reviews. Immunology · doi:10.1038/nri3818 · Cited by 1,207
Meisel, C., Schefold, J. C., Pschowski, R., Baumann, T., Hetzger, K., Gregor, J., Weber-Carstens, S., Hasper, D., Keh, D., Zuckermann, H., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0363oc · Cited by 648
Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response
Sokol, C. L., Chu, N.-Q., Yu, S., Nish, S. A., Laufer, T. M., & Medzhitov, R. (2009) · Nature Immunology · doi:10.1038/ni.1738 · Cited by 619
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
Bowman, R. L., Klemm, F., Akkari, L., Pyonteck, S. M., Sevenich, L., Quail, D. F., Dhara, S., Simpson, K., Gardner, E. E., Iacobuzio-Donahue, C. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.052 · Cited by 619
Metadata
- Authors
- Reith, W., LeibundGut-Landmann, S., & Waldburger, J.-M.
- Venue
- Nature Reviews Immunology
- Published
- 2005-10
- Volume
- 5
- Issue
- 10
- Pages
- 793-806
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2015848550
- Cited by
- 462
- References
- 129
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.